Walmart generic drug discounts often offer more patient savings

July 24, 2018

(HealthDay)—Walmart's Generic Drug Discount Program (GDDP), which sells many commonly used generic medications for $4 per 30-day supply, offers savings over Medicare for some generic cardiovascular medications, according to a research letter published online July 24 in the Annals of Internal Medicine.

Patrick Liu, from the Yale School of Medicine in New Haven, Conn., and colleagues compared Medicare beneficiary out-of-pocket costs through prescription drug plans (PDPs) with $4 GDDP cash prices using Walmart's September 2017 GDDP list, focusing on used to treat seven prevalent cardiovascular disease (CVD)-related conditions. The proportion of plans requiring patients to spend more than $4 out of pocket to obtain a 30-day supply for covered medications and each drug's median out-of-pocket cost were examined as the primary outcomes.

The researchers identified 27 generic medications from Walmart's list used for prevalent CVD-related conditions; Medicare PDPs covered a median of 25 medications. A median of 21 percent of plans required patients to spend more than $4 out of pocket for covered medications. Across all tiers, the median total out-of-pocket cost of covered medications was $2; significant differences were seen in costs for Medicare Advantage-PDPs (MA-PDPs) and stand-alone PDPs, with MA-PDPs consistently requiring patients to spend more than stand-alone PDPs.

"A substantial proportion of Medicare PDPs in 2017 required patients to spend more out of pocket than Walmart's GDDP for 30-day supplies of 27 generic medications used to treat prevalent CVD-related conditions," the authors write.

Explore further: Rising costs and potential savings for generic, topical steroids

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Rising costs and potential savings for generic, topical steroids

April 29, 2017
Although topical steroids are among the most commonly prescribed medications by dermatologists, there are limited data on spending and use for this class of drugs. In a new study led by investigators at Brigham and Women's ...

The rising price of Medicare Part D's 10 most costly medications

July 5, 2018
Perhaps surprising no one, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have found that the cost for the 10 "highest spend" medications in Medicare Part D—the ...

Coverage policies compared for back pain medications

June 25, 2018
(HealthDay)—There are opportunities for recalibrating the role of opioids in pain care, including expanding access to opioid alternatives through coverage and reimbursement policies, according to a study published online ...

Generic eye drops for seniors could save millions of dollars a year

July 28, 2017
(HealthDay)—Prescribing generic drugs for seniors' eye problems could save the U.S. government hundreds of millions of dollars a year, a new study suggests.

Seniors scrimp but still spend more for meds

June 4, 2018
Medicare recipients filled fewer prescriptions for pricey brand-name drugs—but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and ...

Recommended for you

US approves first generic competitor to Mylan's EpiPen

August 16, 2018
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring prices for the original version owned by Mylan stoked controversy.

Study: What patients really think about opioid vs non-opioid medications for chronic pain

August 14, 2018
Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone ...

Doctors nudged by overdose letter prescribe fewer opioids

August 9, 2018
In a novel experiment, doctors got a letter from the medical examiner's office telling them of their patient's fatal overdose. The response: They started prescribing fewer opioids.

Benzodiazepine and related drug prescriptions have increased among young people in Sweden

August 7, 2018
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 ...

Unwise opioids for wisdom teeth: Study shows link to long-term use in teens and young adults

August 7, 2018
Getting wisdom teeth removed may be a rite of passage for many teens and young adults, but the opioid painkiller prescriptions that many of them receive could set them on a path to long-term opioid use, a new study finds.

Behavioral nudges lead to striking drop in prescriptions of potent antipsychotic

August 1, 2018
A study led by Columbia University's Mailman School of Public Health has found that letters targeting high prescribers of Seroquel (quetiapine), an antipsychotic with potentially harmful side effects in the elderly, significantly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.